SMS Pharmaceuticals Reports Positive Financial Results for Q2 2024, Receives 'Hold' Stock Call
The company's PAT and Net Sales have shown significant growth, and its Debt-Equity Ratio is at its lowest in the last five half-yearly periods.
SMS Pharmaceuticals, a smallcap company in the pharmaceuticals and drugs industry, has recently announced its financial results for the quarter ending September 2024. The results have been declared on November 8, 2024.According to MarketsMOJO, a leading financial analysis platform, the stock call for SMS Pharma is 'Hold'. This indicates that the company's stock is expected to perform steadily in the near future.
The company has shown a positive financial performance in the second quarter of the fiscal year 2024-2025. In the last three months, the company's score has fallen from 18 to 11, indicating a positive trend.
Based on the financials of September 2024, there are a few key factors that are working in favor of SMS Pharma. The company's Profit After Tax (PAT) for the half-yearly period has grown by 45.14% year on year, reaching Rs 30.58 crore. The near-term trend for PAT is also very positive.
In terms of Net Sales, the company has shown a growth of 34.47% year on year for the nine-month period, reaching Rs 607.00 crore. The near-term trend for sales is also positive.
Another positive aspect for SMS Pharma is its Debt-Equity Ratio, which is at its lowest in the last five half-yearly periods at 0.51 times. This indicates that the company has been reducing its borrowing in comparison to its equity capital.
Overall, the financial results for the quarter ending September 2024 have been positive for SMS Pharmaceuticals. With a 'Hold' stock call from MarketsMOJO, the company is expected to continue its steady performance in the near future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
